Fragmento

A 64-year-old woman with history of chronic hepatitis related to Hepatitis C virus [(HCV), genotype 1b] infection received treatment with pegylated interferon (PEG-IFNá2a) and rivabirin noticed a black coloration of her tongue during the thirtythird week of treatment. She had no other relevant past medical history and was a nonsmoker. She did not refer any pain, discomfort or other symptoms in the oral cavity. Physical examination showed a black hyperpigmentation and elongation of the phylliform papillae on the dorsal surface of the tongue. After appropriate diagnosis and counseling, pigmentation attenuated and later disappeared allowing completion of therapy.

Palabras clave:

2015-04-07   |   662 visitas   |   Evalua este artículo 0 valoraciones

Vol. 14 Núm.3. Mayo-Junio 2015 Pags. 414-415 Ann Hepatol 2015; 14(3)